Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 09, 2018 07:00 ET | Source: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

COMPANY TO HOST AN INVESTOR CONFERENCE CALL ONTHURSDAY, AUGUST 9, 2018 AT 8:00 AM EDT BOSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage...
August 08, 2018 08:00 ET | Source: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals to Present at the 2018 Wedbush PacGrow Healthcare Conference

BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform...
August 01, 2018 08:00 ET | Source: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals to Host Second Quarter 2018 Investor Call and Corporate Update on August 9, 2018

BOSTON, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform...
May 31, 2018 08:00 ET | Source: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals to Present at Jefferies 2018 Global Healthcare Conference

BOSTON, May 31, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform...
May 10, 2018 07:00 ET | Source: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update

COMPANY TO HOST AN INVESTOR CONFERENCE CALL ONTHURSDAY, MAY 10, 2018 AT 8:00 AM EDT BOSTON, May 10, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage...
May 03, 2018 08:00 ET | Source: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals to Present at 43rd Annual Deutsche Bank Health Care Conference

BOSTON, May 03, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform...